Global Digital Therapeutics and Wellness

Digital Therapeutics and Wellness Comprehensive Study by Type (Device, Software), Application (Cardiovascular Disease & Hypertension, Diabetes & Prediabetes, Obesity & Weight Loss, Smoking Cessation, Others), End Users (Individual, Enterprise), Operating systems (Android, IOS) Players and Region - Global Market Outlook to 2028

Digital Therapeutics and Wellness Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Digital Therapeutics and Wellness
Digital therapeutics uses digital health technologies to treat medical or psychological condition. These treatment depends on the lifestyle as well as behavioral changes. Digital therapeutics has various benefits such as lower costs, monitoring, guidance and social support. Moreover, these are used independently or with medications, therapy and devices which optimises the health outcomes. It also empowers the patients and other health care providers by accessing tools to treat wide range of conditions.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The key manufacturers are targeting the innovations of the services with better quality, and better technical characteristics, and also assist in providing and humanizing the after-sale service to the consumers. The key players are probable to keep a stronghold on the market over the anticipated period. The key players are accepting strategic decisions and are thinking about mergers and acquisitions in order to maintain their presence in the market. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Digital Therapeutics and Wellness market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Proteus Digital Health (United States), Omada Health (United States), Welldoc (United States), Livongo Health (United States), Noom (United States), Ginger (United States), Reciprocal Labs Corporation (United States), 2morrow Inc. (United States), Canary Health (United States) and Mango Health (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are My mHealth (United Kingdom), Glytec (United States), Proteus (United States) and Vida Health (United States).

Segmentation Overview
AMA Research has segmented the market of Global Digital Therapeutics and Wellness market by Type (Device and Software), Application (Cardiovascular Disease & Hypertension, Diabetes & Prediabetes, Obesity & Weight Loss, Smoking Cessation and Others) and Region.



On the basis of geography, the market of Digital Therapeutics and Wellness has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Users, the sub-segment i.e. Individual will boost the Digital Therapeutics and Wellness market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Operating systems , the sub-segment i.e. Android will boost the Digital Therapeutics and Wellness market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Usage of Health Apps and Technological Advancements in Health Apps

Market Growth Drivers:
Increasing Health Consciousness among Individuals and Growing Awareness among the Users about Digital Therapeutics and Wellness

Challenges:
Lack of Precision may hamper the Market Growth

Restraints:
High Costs Associated with Premium Features

Opportunities:
Rising Adoption of Smartphones with Advanced Connectivity and Increasing Number of Digital Therapeutics in the Market

Market Leaders and their expansionary development strategies
In November 2023, Akili Interactive has launched Akili Studio, a new cognitive training program for adults. Akili Studio is a personalized cognitive training program that uses a variety of cognitive exercises to help improve memory, attention, and processing speed.
In November 2023, Pear Therapeutics, a company specializing in prescription digital therapeutics (PDTs), has partnered with Otsuka Pharmaceutical, a leading global healthcare company, to co-develop and commercialize PDTs for various conditions, including insomnia and major depressive disorder. This partnership will combine Pear's expertise in PDT development with Otsuka's global reach and commercialization capabilities.


Key Target Audience
Software Providers, Device manufacturers, Government Regulatory Bodies, Government Research Organisations, Private Research Organisations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Device
  • Software
By Application
  • Cardiovascular Disease & Hypertension
  • Diabetes & Prediabetes
  • Obesity & Weight Loss
  • Smoking Cessation
  • Others
By End Users
  • Individual
  • Enterprise

By Operating systems
  • Android
  • IOS

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Health Consciousness among Individuals
      • 3.2.2. Growing Awareness among the Users about Digital Therapeutics and Wellness
    • 3.3. Market Challenges
      • 3.3.1. Lack of Precision may hamper the Market Growth
    • 3.4. Market Trends
      • 3.4.1. Increasing Usage of Health Apps
      • 3.4.2. Technological Advancements in Health Apps
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Digital Therapeutics and Wellness, by Type, Application, End Users, Operating systems and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Digital Therapeutics and Wellness (Value)
      • 5.2.1. Global Digital Therapeutics and Wellness by: Type (Value)
        • 5.2.1.1. Device
        • 5.2.1.2. Software
      • 5.2.2. Global Digital Therapeutics and Wellness by: Application (Value)
        • 5.2.2.1. Cardiovascular Disease & Hypertension
        • 5.2.2.2. Diabetes & Prediabetes
        • 5.2.2.3. Obesity & Weight Loss
        • 5.2.2.4. Smoking Cessation
        • 5.2.2.5. Others
      • 5.2.3. Global Digital Therapeutics and Wellness by: End Users (Value)
        • 5.2.3.1. Individual
        • 5.2.3.2. Enterprise
      • 5.2.4. Global Digital Therapeutics and Wellness Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Digital Therapeutics and Wellness: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Proteus Digital Health (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Omada Health (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Welldoc (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Livongo Health (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Noom (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Ginger (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Reciprocal Labs Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. 2morrow Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Canary Health (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Mango Health (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Digital Therapeutics and Wellness Sale, by Type, Application, End Users, Operating systems and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Digital Therapeutics and Wellness (Value)
      • 7.2.1. Global Digital Therapeutics and Wellness by: Type (Value)
        • 7.2.1.1. Device
        • 7.2.1.2. Software
      • 7.2.2. Global Digital Therapeutics and Wellness by: Application (Value)
        • 7.2.2.1. Cardiovascular Disease & Hypertension
        • 7.2.2.2. Diabetes & Prediabetes
        • 7.2.2.3. Obesity & Weight Loss
        • 7.2.2.4. Smoking Cessation
        • 7.2.2.5. Others
      • 7.2.3. Global Digital Therapeutics and Wellness by: End Users (Value)
        • 7.2.3.1. Individual
        • 7.2.3.2. Enterprise
      • 7.2.4. Global Digital Therapeutics and Wellness Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Digital Therapeutics and Wellness: by Type(USD Million)
  • Table 2. Digital Therapeutics and Wellness Device , by Region USD Million (2017-2022)
  • Table 3. Digital Therapeutics and Wellness Software , by Region USD Million (2017-2022)
  • Table 4. Digital Therapeutics and Wellness: by Application(USD Million)
  • Table 5. Digital Therapeutics and Wellness Cardiovascular Disease & Hypertension , by Region USD Million (2017-2022)
  • Table 6. Digital Therapeutics and Wellness Diabetes & Prediabetes , by Region USD Million (2017-2022)
  • Table 7. Digital Therapeutics and Wellness Obesity & Weight Loss , by Region USD Million (2017-2022)
  • Table 8. Digital Therapeutics and Wellness Smoking Cessation , by Region USD Million (2017-2022)
  • Table 9. Digital Therapeutics and Wellness Others , by Region USD Million (2017-2022)
  • Table 10. Digital Therapeutics and Wellness: by End Users(USD Million)
  • Table 11. Digital Therapeutics and Wellness Individual , by Region USD Million (2017-2022)
  • Table 12. Digital Therapeutics and Wellness Enterprise , by Region USD Million (2017-2022)
  • Table 13. South America Digital Therapeutics and Wellness, by Country USD Million (2017-2022)
  • Table 14. South America Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 15. South America Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 16. South America Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 17. South America Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 18. Brazil Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 19. Brazil Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 20. Brazil Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 21. Brazil Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 22. Argentina Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 23. Argentina Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 24. Argentina Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 25. Argentina Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 26. Rest of South America Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 27. Rest of South America Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 28. Rest of South America Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 29. Rest of South America Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 30. Asia Pacific Digital Therapeutics and Wellness, by Country USD Million (2017-2022)
  • Table 31. Asia Pacific Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 32. Asia Pacific Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 33. Asia Pacific Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 34. Asia Pacific Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 35. China Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 36. China Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 37. China Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 38. China Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 39. Japan Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 40. Japan Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 41. Japan Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 42. Japan Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 43. India Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 44. India Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 45. India Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 46. India Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 47. South Korea Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 48. South Korea Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 49. South Korea Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 50. South Korea Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 51. Taiwan Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 52. Taiwan Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 53. Taiwan Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 54. Taiwan Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 55. Australia Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 56. Australia Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 57. Australia Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 58. Australia Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 59. Rest of Asia-Pacific Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 60. Rest of Asia-Pacific Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 61. Rest of Asia-Pacific Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 62. Rest of Asia-Pacific Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 63. Europe Digital Therapeutics and Wellness, by Country USD Million (2017-2022)
  • Table 64. Europe Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 65. Europe Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 66. Europe Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 67. Europe Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 68. Germany Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 69. Germany Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 70. Germany Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 71. Germany Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 72. France Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 73. France Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 74. France Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 75. France Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 76. Italy Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 77. Italy Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 78. Italy Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 79. Italy Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 80. United Kingdom Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 81. United Kingdom Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 82. United Kingdom Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 83. United Kingdom Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 84. Netherlands Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 85. Netherlands Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 86. Netherlands Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 87. Netherlands Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 88. Rest of Europe Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 89. Rest of Europe Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 90. Rest of Europe Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 91. Rest of Europe Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 92. MEA Digital Therapeutics and Wellness, by Country USD Million (2017-2022)
  • Table 93. MEA Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 94. MEA Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 95. MEA Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 96. MEA Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 97. Middle East Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 98. Middle East Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 99. Middle East Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 100. Middle East Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 101. Africa Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 102. Africa Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 103. Africa Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 104. Africa Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 105. North America Digital Therapeutics and Wellness, by Country USD Million (2017-2022)
  • Table 106. North America Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 107. North America Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 108. North America Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 109. North America Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 110. United States Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 111. United States Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 112. United States Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 113. United States Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 114. Canada Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 115. Canada Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 116. Canada Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 117. Canada Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 118. Mexico Digital Therapeutics and Wellness, by Type USD Million (2017-2022)
  • Table 119. Mexico Digital Therapeutics and Wellness, by Application USD Million (2017-2022)
  • Table 120. Mexico Digital Therapeutics and Wellness, by End Users USD Million (2017-2022)
  • Table 121. Mexico Digital Therapeutics and Wellness, by Operating systems USD Million (2017-2022)
  • Table 122. Company Basic Information, Sales Area and Its Competitors
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Digital Therapeutics and Wellness: by Type(USD Million)
  • Table 133. Digital Therapeutics and Wellness Device , by Region USD Million (2023-2028)
  • Table 134. Digital Therapeutics and Wellness Software , by Region USD Million (2023-2028)
  • Table 135. Digital Therapeutics and Wellness: by Application(USD Million)
  • Table 136. Digital Therapeutics and Wellness Cardiovascular Disease & Hypertension , by Region USD Million (2023-2028)
  • Table 137. Digital Therapeutics and Wellness Diabetes & Prediabetes , by Region USD Million (2023-2028)
  • Table 138. Digital Therapeutics and Wellness Obesity & Weight Loss , by Region USD Million (2023-2028)
  • Table 139. Digital Therapeutics and Wellness Smoking Cessation , by Region USD Million (2023-2028)
  • Table 140. Digital Therapeutics and Wellness Others , by Region USD Million (2023-2028)
  • Table 141. Digital Therapeutics and Wellness: by End Users(USD Million)
  • Table 142. Digital Therapeutics and Wellness Individual , by Region USD Million (2023-2028)
  • Table 143. Digital Therapeutics and Wellness Enterprise , by Region USD Million (2023-2028)
  • Table 144. South America Digital Therapeutics and Wellness, by Country USD Million (2023-2028)
  • Table 145. South America Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 146. South America Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 147. South America Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 148. South America Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 149. Brazil Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 150. Brazil Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 151. Brazil Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 152. Brazil Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 153. Argentina Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 154. Argentina Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 155. Argentina Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 156. Argentina Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 157. Rest of South America Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 158. Rest of South America Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 159. Rest of South America Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 160. Rest of South America Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 161. Asia Pacific Digital Therapeutics and Wellness, by Country USD Million (2023-2028)
  • Table 162. Asia Pacific Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 163. Asia Pacific Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 164. Asia Pacific Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 165. Asia Pacific Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 166. China Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 167. China Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 168. China Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 169. China Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 170. Japan Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 171. Japan Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 172. Japan Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 173. Japan Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 174. India Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 175. India Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 176. India Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 177. India Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 178. South Korea Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 179. South Korea Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 180. South Korea Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 181. South Korea Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 182. Taiwan Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 183. Taiwan Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 184. Taiwan Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 185. Taiwan Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 186. Australia Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 187. Australia Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 188. Australia Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 189. Australia Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 190. Rest of Asia-Pacific Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 191. Rest of Asia-Pacific Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 192. Rest of Asia-Pacific Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 193. Rest of Asia-Pacific Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 194. Europe Digital Therapeutics and Wellness, by Country USD Million (2023-2028)
  • Table 195. Europe Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 196. Europe Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 197. Europe Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 198. Europe Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 199. Germany Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 200. Germany Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 201. Germany Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 202. Germany Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 203. France Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 204. France Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 205. France Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 206. France Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 207. Italy Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 208. Italy Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 209. Italy Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 210. Italy Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 211. United Kingdom Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 212. United Kingdom Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 213. United Kingdom Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 214. United Kingdom Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 215. Netherlands Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 216. Netherlands Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 217. Netherlands Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 218. Netherlands Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 219. Rest of Europe Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 220. Rest of Europe Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 221. Rest of Europe Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 222. Rest of Europe Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 223. MEA Digital Therapeutics and Wellness, by Country USD Million (2023-2028)
  • Table 224. MEA Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 225. MEA Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 226. MEA Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 227. MEA Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 228. Middle East Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 229. Middle East Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 230. Middle East Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 231. Middle East Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 232. Africa Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 233. Africa Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 234. Africa Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 235. Africa Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 236. North America Digital Therapeutics and Wellness, by Country USD Million (2023-2028)
  • Table 237. North America Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 238. North America Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 239. North America Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 240. North America Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 241. United States Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 242. United States Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 243. United States Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 244. United States Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 245. Canada Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 246. Canada Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 247. Canada Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 248. Canada Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 249. Mexico Digital Therapeutics and Wellness, by Type USD Million (2023-2028)
  • Table 250. Mexico Digital Therapeutics and Wellness, by Application USD Million (2023-2028)
  • Table 251. Mexico Digital Therapeutics and Wellness, by End Users USD Million (2023-2028)
  • Table 252. Mexico Digital Therapeutics and Wellness, by Operating systems USD Million (2023-2028)
  • Table 253. Research Programs/Design for This Report
  • Table 254. Key Data Information from Secondary Sources
  • Table 255. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Digital Therapeutics and Wellness: by Type USD Million (2017-2022)
  • Figure 5. Global Digital Therapeutics and Wellness: by Application USD Million (2017-2022)
  • Figure 6. Global Digital Therapeutics and Wellness: by End Users USD Million (2017-2022)
  • Figure 7. South America Digital Therapeutics and Wellness Share (%), by Country
  • Figure 8. Asia Pacific Digital Therapeutics and Wellness Share (%), by Country
  • Figure 9. Europe Digital Therapeutics and Wellness Share (%), by Country
  • Figure 10. MEA Digital Therapeutics and Wellness Share (%), by Country
  • Figure 11. North America Digital Therapeutics and Wellness Share (%), by Country
  • Figure 12. Global Digital Therapeutics and Wellness share by Players 2022 (%)
  • Figure 13. Global Digital Therapeutics and Wellness share by Players (Top 3) 2022(%)
  • Figure 14. Global Digital Therapeutics and Wellness share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Proteus Digital Health (United States) Revenue, Net Income and Gross profit
  • Figure 17. Proteus Digital Health (United States) Revenue: by Geography 2022
  • Figure 18. Omada Health (United States) Revenue, Net Income and Gross profit
  • Figure 19. Omada Health (United States) Revenue: by Geography 2022
  • Figure 20. Welldoc (United States) Revenue, Net Income and Gross profit
  • Figure 21. Welldoc (United States) Revenue: by Geography 2022
  • Figure 22. Livongo Health (United States) Revenue, Net Income and Gross profit
  • Figure 23. Livongo Health (United States) Revenue: by Geography 2022
  • Figure 24. Noom (United States) Revenue, Net Income and Gross profit
  • Figure 25. Noom (United States) Revenue: by Geography 2022
  • Figure 26. Ginger (United States) Revenue, Net Income and Gross profit
  • Figure 27. Ginger (United States) Revenue: by Geography 2022
  • Figure 28. Reciprocal Labs Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 29. Reciprocal Labs Corporation (United States) Revenue: by Geography 2022
  • Figure 30. 2morrow Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. 2morrow Inc. (United States) Revenue: by Geography 2022
  • Figure 32. Canary Health (United States) Revenue, Net Income and Gross profit
  • Figure 33. Canary Health (United States) Revenue: by Geography 2022
  • Figure 34. Mango Health (United States) Revenue, Net Income and Gross profit
  • Figure 35. Mango Health (United States) Revenue: by Geography 2022
  • Figure 36. Global Digital Therapeutics and Wellness: by Type USD Million (2023-2028)
  • Figure 37. Global Digital Therapeutics and Wellness: by Application USD Million (2023-2028)
  • Figure 38. Global Digital Therapeutics and Wellness: by End Users USD Million (2023-2028)
  • Figure 39. South America Digital Therapeutics and Wellness Share (%), by Country
  • Figure 40. Asia Pacific Digital Therapeutics and Wellness Share (%), by Country
  • Figure 41. Europe Digital Therapeutics and Wellness Share (%), by Country
  • Figure 42. MEA Digital Therapeutics and Wellness Share (%), by Country
  • Figure 43. North America Digital Therapeutics and Wellness Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Proteus Digital Health (United States)
  • Omada Health (United States)
  • Welldoc (United States)
  • Livongo Health (United States)
  • Noom (United States)
  • Ginger (United States)
  • Reciprocal Labs Corporation (United States)
  • 2morrow Inc. (United States)
  • Canary Health (United States)
  • Mango Health (United States)
Additional players considered in the study are as follows:
My mHealth (United Kingdom) , Glytec (United States) , Proteus (United States) , Vida Health (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 229 Pages 89 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Digital Therapeutics and Wellness Quantitative research analysis
Global Digital Therapeutics and Wellness Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Proteus Digital Health (United States), Omada Health (United States), Welldoc (United States), Livongo Health (United States), Noom (United States), Ginger (United States), Reciprocal Labs Corporation (United States), 2morrow Inc. (United States), Canary Health (United States) and Mango Health (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Usage of Health Apps " is seen as one of major influencing trends for Digital Therapeutics and Wellness Market during projected period 2022-2028.
The Digital Therapeutics and Wellness market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Digital Therapeutics and Wellness Report?

Have a Query? Click Here

Other Related Reports

Veterinary Telemedicine Platform Comprehensive Study by Type (Real-time Chat, Radiology Consulting, Others), Application (Livestock Animals {Poultry, Swine, Cattle, Fish}, Companion Animals {Dogs, Ca...
$ 3750
Transcatheter Aortic Valve Implantation (TAVI) Comprehensive Study by Type (Transfemoral Implantation, Transapical Implantation, Transaortic Implantation), Application (Hospitals & Clinics, Academic ...
$ 3350
Head Lice Infestation Treatment Comprehensive Study by Type (Lotion, Creams, Shampoo), Treatment Type (Topical Pediculicides (Malathion, Permethrin), Wet Combing, Oral Therapy), End User (Childrens, ...
$ 3500
Nutrigenomics Testing Comprehensive Study by Application (Obesity, Diabetes, Cardiovascular Diseases, Cancer Research, Women's Health, Neurological, Others), Distribution Channel (Hospitals & Clinics...
$ 3500
Ayurveda Comprehensive Study by Application (Gastrointestinal Diseases, Cardiac Disorders, Respiratory Disorders, Psychological Disorders, Movement Disorders, Others), Treatment (Vamana, Virechana, N...
$ 3650
Single Cell Isolation Systems Comprehensive Study by Type (Flow Cytometry Systems, Microfluidic Systems, Laser Microdissection Systems, Others), Application (Drug Discovery, Life Science Research, Ot...
$ 3450